T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis

MLA

Daria Briukhovetska, et al. “T Cell-Derived Interleukin-22 Drives the Expression of CD155 by Cancer Cells to Suppress NK Cell Function and Promote Metastasis.” Immunity, Jan. 2023. EBSCOhost, https://doi.org/10.1016/j.immuni.2022.12.010.

APA

Daria Briukhovetska, Javier Suarez-Gosalvez, Cornelia Voigt, Anamarija Markota, Anastasios D. Giannou, Maryam Schübel, Jakob Jobst, Tao Zhang, Janina Dörr, Florian Märkl, Lina Majed, Philipp Jie Müller, Peter May, Adrian Gottschlich, Nicholas Tokarew, Jöran Lücke, Arman Oner, Melanie Schwerdtfeger, David Andreu-Sanz, … Sebastian Kobold. (2023). T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis. Immunity. https://doi.org/10.1016/j.immuni.2022.12.010

Chicago

Daria Briukhovetska, Javier Suarez-Gosalvez, Cornelia Voigt, Anamarija Markota, Anastasios D. Giannou, Maryam Schübel, Jakob Jobst, et al. 2023. “T Cell-Derived Interleukin-22 Drives the Expression of CD155 by Cancer Cells to Suppress NK Cell Function and Promote Metastasis.” Immunity, January. doi:10.1016/j.immuni.2022.12.010.